Literature DB >> 27587741

A Prospective Clinical and Radiological Evaluation at 5 Years After Arthroscopic Matrix-Induced Autologous Chondrocyte Implantation.

Jay R Ebert1, Michael Fallon2, David J Wood3, Gregory C Janes4.   

Abstract

BACKGROUND: While midterm outcomes after matrix-induced autologous chondrocyte implantation (MACI) are encouraging, the procedure permits an arthroscopic approach that may reduce the morbidity of arthrotomy and permit accelerated rehabilitation. HYPOTHESIS: A significant improvement in clinical and radiological outcomes after arthroscopic MACI will exist through to 5 years after surgery. STUDY
DESIGN: Case series; Level of evidence, 4.
METHODS: We prospectively evaluated the first 31 patients (15 male, 16 female) who underwent MACI via arthroscopic surgery to address symptomatic tibiofemoral chondral lesions. MACI was followed by a structured rehabilitation program in all patients. Clinical scores were administered preoperatively and at 3 and 6 months as well as 1, 2, and 5 years after surgery. These included the Knee injury and Osteoarthritis Outcome Score (KOOS), Lysholm knee scale (LKS), Tegner activity scale (TAS), visual analog scale for pain, Short Form-36 Health Survey (SF-36), active knee motion, and 6-minute walk test. Isokinetic dynamometry was used to assess peak knee extension and flexion strength and limb symmetry indices (LSIs) between the operated and nonoperated limbs. High-resolution magnetic resonance imaging (MRI) was performed at 3 months and at 1, 2, and 5 years postoperatively to evaluate graft repair as well as calculate the MRI composite score.
RESULTS: There was a significant improvement ( P < .05) in all KOOS subscale scores, LKS and TAS scores, the SF-36 physical component score, pain frequency and severity, active knee flexion and extension, and 6-minute walk distance. Isokinetic knee extension strength significantly improved, and all knee extension and flexion LSIs were above 90% (apart from peak knee extension strength at 1 year). At 5 years, 93% of patients were satisfied with MACI to relieve their pain, 90% were satisfied with improving their ability to undertake daily activities, and 80% were satisfied with the improvement in participating in sport. Graft infill ( P = .033) and the MRI composite score ( P = .028) significantly improved over time, with 90% of patients demonstrating good to excellent tissue infill at 5 years. There were 2 graft failures at 5 years after surgery.
CONCLUSION: The arthroscopically performed MACI technique demonstrated good clinical and radiological outcomes up to 5 years, with high levels of patient satisfaction.

Entities:  

Keywords:  arthroscopic surgery; clinical outcomes; magnetic resonance imaging (MRI); matrix-induced autologous chondrocyte implantation (MACI); rehabilitation

Mesh:

Year:  2016        PMID: 27587741     DOI: 10.1177/0363546516663493

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  16 in total

Review 1.  Surgical and tissue engineering strategies for articular cartilage and meniscus repair.

Authors:  Heenam Kwon; Wendy E Brown; Cassandra A Lee; Dean Wang; Nikolaos Paschos; Jerry C Hu; Kyriacos A Athanasiou
Journal:  Nat Rev Rheumatol       Date:  2019-07-11       Impact factor: 20.543

2.  Arthroscopic gel-type autologous chondrocyte implantation presents histologic evidence of regenerating hyaline-like cartilage in the knee with articular cartilage defect.

Authors:  Tae-Hwan Yoon; Min Jung; Chong-Hyuk Choi; Hyoung-Sik Kim; Young-Han Lee; Yun-Seok Choi; Sung-Jae Kim; Sung-Hwan Kim
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-06-25       Impact factor: 4.342

3.  Correlation between the quality of cartilage repair tissue and patellofemoral osteoarthritis after matrix-induced autologous chondrocyte implantation at three-year follow-up: a cross-sectional study.

Authors:  Jialing Lyu; Hongli Geng; Weimin Zhu; Dingfu Li; Kang Chen; Hui Ye; Jun Xia
Journal:  Int Orthop       Date:  2022-10-05       Impact factor: 3.479

4.  Matrix-induced autologous chondrocyte implantation (mACI) versus autologous matrix-induced chondrogenesis (AMIC) for chondral defects of the knee: a systematic review.

Authors:  Filippo Migliorini; Jörg Eschweiler; Christian Götze; Arne Driessen; Markus Tingart; Nicola Maffulli
Journal:  Br Med Bull       Date:  2022-03-21       Impact factor: 5.841

5.  Cartiform Implantation for focal cartilage defects in the knee: A 2-year clinical and magnetic resonance imaging follow-up study.

Authors:  Craig H Bennett; Vidushan Nadarajah; Michelle C Moore; Julio J Jauregui; Andrew G Dubina; Cameran Burt; Derik L Davis; Arvinder Uppal; R Frank Henn
Journal:  J Orthop       Date:  2021-02-23

Review 6.  Algorithm for Treatment of Focal Cartilage Defects of the Knee: Classic and New Procedures.

Authors:  Betina B Hinckel; Dimitri Thomas; Evan E Vellios; Kyle John Hancock; Jacob G Calcei; Seth L Sherman; Claire D Eliasberg; Tiago L Fernandes; Jack Farr; Christian Lattermann; Andreas H Gomoll
Journal:  Cartilage       Date:  2021-03-20       Impact factor: 3.117

Review 7.  Matrix-Assisted Autologous Chondrocyte Transplantation in the Knee: A Systematic Review of Mid- to Long-Term Clinical Outcomes.

Authors:  Hayden B Schuette; Matthew J Kraeutler; Eric C McCarty
Journal:  Orthop J Sports Med       Date:  2017-06-06

8.  Optimization of TGF-β1-transduced chondrocytes for cartilage regeneration in a 3D printed knee joint model.

Authors:  Jiyong Ahn; Seon Ae Kim; Ki Won Kim; Joon Hyuck Oh; Seok Jung Kim
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

Review 9.  Arthroscopy versus mini-arthrotomy approach for matrix-induced autologous chondrocyte implantation in the knee: a systematic review.

Authors:  Filippo Migliorini; Jörg Eschweiler; Filippo Spiezia; Bryan J M van de Wall; Matthias Knobe; Markus Tingart; Nicola Maffulli
Journal:  J Orthop Traumatol       Date:  2021-06-16

Review 10.  Patellofemoral Cartilage Repair.

Authors:  Alexandre Barbieri Mestriner; Jakob Ackermann; Andreas H Gomoll
Journal:  Curr Rev Musculoskelet Med       Date:  2018-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.